Document Detail


Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study.
MedLine Citation:
PMID:  18635689     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Gamma-hydroxybutyric acid (GHB) is a drug currently used for the treatment of alcohol dependence. The aim of our study was to investigate the incidence of craving for and abuse of GHB in 47 patients enrolled and divided into four groups: group A (pure alcoholics), group B (alcoholics with a sustained full remission from cocaine dependence), group C (alcoholics with a sustained full remission from heroin dependence) and group D (alcoholics in a methadone maintenance treatment [MMT] programme). All patients were treated with an oral dose of GHB (50 mg/kg of body weight t.i.d.) for three months. Craving for GHB was statistically significant higher in group B than in group A (P < 0.001), C (P = 0.01) and D (P < 0.001), and in group C than in group D (P < 0.05). Abuse of GHB proved to be statistically significant higher in group B than in group A (P < 0.001) and D (P < 0.01), and in group C than in group A (P = 0.01) and D (P < 0.05). Thus, the administration of GHB in alcoholics with a sustained full remission from heroin or cocaine dependence is not recommended; however, this should not discourage physicians from using GHB for the treatment of pure alcoholics or alcohol dependents following a MMT.
Authors:
F Caputo; S Francini; M Stoppo; F Lorenzini; T Vignoli; A Del Re; C Comaschi; L Leggio; G Addolorato; G Zoli; M Bernardi
Related Documents :
7404309 - Prevention of alcohol withdrawal symptoms in surgical patients.
18706769 - Relapse to smoking after 1 year of abstinence: a meta-analysis.
24251239 - Carotid and vagal body paragangliomas.
7186589 - Stuttering: the results of 5 days treatment with an airflow technique.
18176949 - The course of illness following inpatient treatment of adults with longstanding eating ...
9134079 - Patient treatment choice and compliance. data from a substance abuse treatment program.
16600829 - A description of intraoperative and postanesthesia complication rates.
19538229 - Midterm results of passive containment surgery using the acorn cor cap cardiac support ...
6362559 - Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavu...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2008-07-17
Journal Detail:
Title:  Journal of psychopharmacology (Oxford, England)     Volume:  23     ISSN:  1461-7285     ISO Abbreviation:  J. Psychopharmacol. (Oxford)     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-06     Completed Date:  2010-01-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907828     Medline TA:  J Psychopharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  883-90     Citation Subset:  IM    
Affiliation:
G. Fontana Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Internal Medicine, Cardioangiology and Hepatology, University of Bologna, Bologna, Italy. fabio-caputo@libero.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Alcoholics*
Alcoholism / drug therapy*
Female
Humans
Hydroxybutyrates / adverse effects*
Male
Middle Aged
Substance-Related Disorders / etiology*
Chemical
Reg. No./Substance:
0/Hydroxybutyrates; 591-81-1/4-hydroxybutyric acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and act...
Next Document:  Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active...